Found: 5
Select item for more details and to access through your institution.
Longitudinal trajectory of Amyloid‐related hippocampal subfield atrophy in nondemented elderly.
- Published in:
- Human Brain Mapping, 2020, v. 41, n. 8, p. 2037, doi. 10.1002/hbm.24928
- By:
- Publication type:
- Article
Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study.
- Published in:
- Cerebrovascular Diseases, 2020, v. 49, n. 2, p. 192, doi. 10.1159/000506070
- By:
- Publication type:
- Article
Effect of Combined Treatment with MLC601 (NeuroAiD<sup>TM</sup>) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies.
- Published in:
- Cerebrovascular Diseases, 2018, v. 46, n. 1/2, p. 82, doi. 10.1159/000492625
- By:
- Publication type:
- Article
The NeuroAiD II (MLC901) in Vascular Cognitive Impairment Study (NEURITES).
- Published in:
- Cerebrovascular Diseases, 2013, v. 35, p. 23, doi. 10.1159/000346234
- By:
- Publication type:
- Article
The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 38, doi. 10.1016/j.trci.2018.12.001
- By:
- Publication type:
- Article